# Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/antitumor-activity-of-thalidomide-in-refractory-multiple-myeloma/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Seema Singhal,Jayesh Mehta,Raman Desikan,Dan Ayers,Paula K. Roberson,Paul Eddlemon,Nikhil C. Munshi,Elias Anaissie,Carla S. Wilson,Madhav V. Dhodapkar,Jerome B. Zeldis,David S. Siegel,John Crowley,Bart Barlogie |
| Citations | 2,595 |
| DOI | 10.1056/nejm199911183412102 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJM199911183412102?articleTools=true |
| OpenAlex ID | https://openalex.org/W2316160054 |
| PMID | 10564685 |
| Type | article |
| Year | 1999 |

## Paper authors

- [Nikhil C. Munshi](https://scholariq.org/researchers/nikhil-c-munshi/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

## Paper topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.